Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Tine Rikke Jørgensen"'
Autor:
Sarah Alulis, Kasper Vadstrup, Jens Olsen, Tine Rikke Jørgensen, Niels Qvist, Pia Munkholm, Andras Borsi
Publikováno v:
BMC Health Services Research, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Patients diagnosed with inflammatory bowel disease may be treated with biologics, depending on several medical and non-medical factors. This study investigated healthcare costs and production values of patients treated with biolog
Externí odkaz:
https://doaj.org/article/cdc5b277ed614a0ebd82015a6a634707
Autor:
Jens Olsen, Andras Borsi, Niels Qvist, Sarah Alulis, Kasper Vadstrup, Tine Rikke Jørgensen, Pia Munkholm
Publikováno v:
Alulis, S, Vadstrup, K, Olsen, J, Jørgensen, T R, Qvist, N, Munkholm, P & Borsi, A 2021, ' The cost burden of Crohn's disease and ulcerative colitis depending on biologic treatment status-a Danish register-based study ', BMC Health Services Research, vol. 21, 836 . https://doi.org/10.1186/s12913-021-06816-3
BMC Health Services Research, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Health Services Research
Alulis, S, Vadstrup, K, Olsen, J, Jørgensen, T R, Qvist, N, Munkholm, P & Borsi, A 2021, ' The cost burden of Crohn’s disease and ulcerative colitis depending on biologic treatment status – a Danish register-based study ', BMC Health Services Research, vol. 21, no. 1 . https://doi.org/10.1186/s12913-021-06816-3
BMC Health Services Research, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Health Services Research
Alulis, S, Vadstrup, K, Olsen, J, Jørgensen, T R, Qvist, N, Munkholm, P & Borsi, A 2021, ' The cost burden of Crohn’s disease and ulcerative colitis depending on biologic treatment status – a Danish register-based study ', BMC Health Services Research, vol. 21, no. 1 . https://doi.org/10.1186/s12913-021-06816-3
Background Patients diagnosed with inflammatory bowel disease may be treated with biologics, depending on several medical and non-medical factors. This study investigated healthcare costs and production values of patients treated with biologics. Meth
Autor:
Sarah Alulis, Andras Borsi, Niels Qvist, Pia Munkholm, Kasper Vadstrup, Agnete Nielsen, Tine Rikke Jørgensen
Publikováno v:
Alulis, S, Vadstrup, K, Borsi, A, Nielsen, A, Rikke Jørgensen, T, Qvist, N & Munkholm, P 2020, ' Treatment patterns for biologics in ulcerative colitis and Crohn’s disease : a Danish Nationwide Register Study from 2003 to 2015 ', Scandinavian Journal of Gastroenterology, vol. 55, no. 3, pp. 265-271 . https://doi.org/10.1080/00365521.2020.1726445
Alulis, S, Vadstrup, K, Borsi, A, Nielsen, A, Jorgensen, T R, Qvist, N & Munkholm, P 2020, ' Treatment patterns for biologics in ulcerative colitis and Crohn's disease: A Danish Nationwide Register Study from 2003 to 2015 ', Journal of Crohn's and Colitis, vol. 14, no. Suppl. 1, pp. S628 . https://doi.org/10.1093/ecco-jcc/jjz203.928
Alulis, S, Vadstrup, K, Borsi, A, Nielsen, A, Jorgensen, T R, Qvist, N & Munkholm, P 2020, ' Treatment patterns for biologics in ulcerative colitis and Crohn's disease: A Danish Nationwide Register Study from 2003 to 2015 ', Journal of Crohn's and Colitis, vol. 14, no. Suppl. 1, pp. S628 . https://doi.org/10.1093/ecco-jcc/jjz203.928
Background: The choice of treatment for Crohn’s disease (CD) and ulcerative colitis (UC) depends among other factors, disease severity. Patients with moderate-to-severe disease should be prescribed biologic response modifiers (biologics), according
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc21aad3e655dba5f313764e5e1ea193
https://findresearcher.sdu.dk:8443/ws/files/168814654/3.4.2020_Treatment_.pdf
https://findresearcher.sdu.dk:8443/ws/files/168814654/3.4.2020_Treatment_.pdf
Autor:
Agnete Nielsen, Pia Munkholm, Niels Qvist, Tine Rikke Jørgensen, Andras Borsi, Kasper Vadstrup, Sarah Alulis, Sandra Elkjaer Stallknecht, C Wennerström
Publikováno v:
Vadstrup, K, Alulis, S, Borsi, A, Elkjaer Stallknecht, S, Nielsen, A, Rikke Jørgensen, T, Wennerström, C, Qvist, N & Munkholm, P 2020, ' Societal costs attributable to Crohn’s disease and ulcerative colitis within the first 5 years after diagnosis : a Danish nationwide cost-of-illness study 2002–2016 ', Scandinavian Journal of Gastroenterology, vol. 55, no. 1, pp. 41-46 . https://doi.org/10.1080/00365521.2019.1707276
Objective: There is little information on cost-of-illness among patients diagnosed with Crohn’s disease (CD) and ulcerative colitis (UC) in Denmark. The objective of this study was to estimate the average 5-year societal costs attributable to CD or
Autor:
Niels Qvist, Tine Rikke Jørgensen, Sarah Alulis, J Olsen, Andras Borsi, Kasper Vadstrup, Pia Munkholm
Publikováno v:
Journal of Crohn's and Colitis. 14:S116-S117
Background Biologic response modifiers (biologics) has been introduced as potent drugs for the treatment of Crohn’s disease (CD) and ulcerative colitis (UC). Whether this has resulted in a reduction in the need for surgical treatment is controversi
Autor:
Tine Rikke Jørgensen, Niels Qvist, E Christina M Wennerström, Pia Munkholm, Andras Borsi, Kasper Vadstrup, Nina Gustafsson, Sarah Alulis, Agnete Nielsen
Publikováno v:
Inflammatory Bowel Diseases
Vadstrup, K, Alulis, S, Borsi, A, Gustafsson, N, Nielsen, A, Wennerström, E C M, Jørgensen, T R, Qvist, N & Munkholm, P 2020, ' Cost Burden of Crohn's Disease and Ulcerative Colitis in the 10-Year Period Before Diagnosis : A Danish Register-Based Study From 2003-2015 ', Inflammatory Bowel Diseases, vol. 26, no. 9, pp. 1377-1382 . https://doi.org/10.1093/ibd/izz265
Vadstrup, K, Alulis, S, Borsi, A, Gustafsson, N, Nielsen, A, Wennerström, E C M, Jørgensen, T R, Qvist, N & Munkholm, P 2020, ' Cost Burden of Crohn's Disease and Ulcerative Colitis in the 10-Year Period Before Diagnosis-A Danish Register-Based Study From 2003-2015 ', Inflammatory Bowel Diseases, vol. 26, no. 9, pp. 1377-1382 . https://doi.org/10.1093/ibd/izz265
Vadstrup, K, Alulis, S, Borsi, A, Gustafsson, N, Nielsen, A, Wennerström, E C M, Jørgensen, T R, Qvist, N & Munkholm, P 2020, ' Cost Burden of Crohn's Disease and Ulcerative Colitis in the 10-Year Period Before Diagnosis : A Danish Register-Based Study From 2003-2015 ', Inflammatory Bowel Diseases, vol. 26, no. 9, pp. 1377-1382 . https://doi.org/10.1093/ibd/izz265
Vadstrup, K, Alulis, S, Borsi, A, Gustafsson, N, Nielsen, A, Wennerström, E C M, Jørgensen, T R, Qvist, N & Munkholm, P 2020, ' Cost Burden of Crohn's Disease and Ulcerative Colitis in the 10-Year Period Before Diagnosis-A Danish Register-Based Study From 2003-2015 ', Inflammatory Bowel Diseases, vol. 26, no. 9, pp. 1377-1382 . https://doi.org/10.1093/ibd/izz265
The cost burden of inflammatory bowel disease is significant 10 years before diagnosis, in addition to other diagnoses related to the digestive system in patients compared with the general population, as investigated using the Danish national registr
Autor:
Pia Munkholm, Kasper Vadstrup, Agnete Nielsen, Tine Rikke Jørgensen, Andras Borsi, Sarah Alulis, Niels Qvist
Publikováno v:
Gastroenterology. 156:S-404
Publikováno v:
Journal of Crohn's and Colitis. 13:S510-S510
Publikováno v:
Journal of Crohn's and Colitis. 13:S519-S519
Publikováno v:
International Journal of Otolaryngology and Head & Neck Surgery. :103-109
Introduction: The incidence of head and neck cancers has increased markedly over the last decade. A Danish study of the costs of head and neck cancers has not been undertaken. Such studies have again become relevant due to the development of the HPV